ALGNALIGN TECHNOLOGY INC

Nasdaq aligntech.com


$ 313.12 $ 2.22 (0.71 %)    

Tuesday, 27-Feb-2024 15:59:57 EST
QQQ $ 437.75 $ 1.05 (0.24 %)
DIA $ 389.71 $ -1.05 (-0.27 %)
SPY $ 507.27 $ 0.94 (0.19 %)
TLT $ 93.00 $ -0.66 (-0.71 %)
GLD $ 188.00 $ -0.20 (-0.11 %)
$ 313.06
$ 312.44
$ 313.06 x 200
$ 313.20 x 100
$ 308.05 - $ 313.36
$ 176.34 - $ 413.20
487,593
na
24.05B
$ 1.80
$ 66.29
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2023 09-30-2023 10-Q
2 08-04-2023 06-30-2023 10-Q
3 05-05-2023 03-31-2023 10-Q
4 02-27-2023 12-31-2022 10-K
5 11-04-2022 09-30-2022 10-Q
6 08-04-2022 06-30-2022 10-Q
7 05-05-2022 03-31-2022 10-Q
8 02-25-2022 12-31-2021 10-K
9 11-02-2021 09-30-2021 10-Q
10 08-04-2021 06-30-2021 10-Q
11 05-05-2021 03-31-2021 10-Q
12 02-26-2021 12-31-2020 10-K
13 10-30-2020 09-30-2020 10-Q
14 07-31-2020 06-30-2020 10-Q
15 05-05-2020 03-31-2020 10-Q
16 02-28-2020 12-31-2019 10-K
17 10-31-2019 09-30-2019 10-Q
18 08-01-2019 06-30-2019 10-Q
19 05-02-2019 03-31-2019 10-Q
20 02-28-2019 12-31-2018 10-K
21 11-01-2018 09-30-2018 10-Q
22 08-02-2018 06-30-2018 10-Q
23 05-03-2018 03-31-2018 10-Q
24 02-28-2018 12-31-2017 10-K
25 11-02-2017 09-30-2017 10-Q
26 08-03-2017 06-30-2017 10-Q
27 05-04-2017 03-31-2017 10-Q
28 02-28-2017 12-31-2016 10-K
29 11-08-2016 09-30-2016 10-Q
30 08-04-2016 06-30-2016 10-Q
31 05-05-2016 03-31-2016 10-Q
32 02-25-2016 12-31-2015 10-K
33 10-29-2015 09-30-2015 10-Q
34 07-30-2015 06-30-2015 10-Q
35 05-01-2015 03-31-2015 10-Q
36 02-26-2015 12-31-2014 10-K
37 10-30-2014 09-30-2014 10-Q
38 07-31-2014 06-30-2014 10-Q
39 05-01-2014 03-31-2014 10-Q
40 02-28-2014 12-31-2013 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 leerink-partners-initiates-coverage-on-align-tech-with-market-perform-rating-announces-price-target-of-310

Leerink Partners analyst Michael Cherny initiates coverage on Align Tech (NASDAQ:ALGN) with a Market Perform rating and anno...

 goldman-sachs-maintains-sell-on-align-tech-raises-price-target-to-225

Goldman Sachs analyst Nathan Rice maintains Align Tech (NASDAQ:ALGN) with a Sell and raises the price target from $197 to $225.

 piper-sandler-maintains-overweight-on-align-tech-raises-price-target-to-335-report-released-on-31-january-2024

Piper Sandler analyst Jason Bednar maintains Align Tech (NASDAQ:ALGN) with a Overweight and raises the price target from $29...

 nasdaq-futures-rebound-as-traders-eye-apple-meta-amazon-earnings-analyst-flags-january-barometer-that-bodes-well-for-the-year

After ending January with modest gains, the major averages now look to earnings catalysts to drive momentum, with futures highe...

 align-technology-q4-earnings-revenue-beat-eps-beat-strong-guidance-and-more

Align's fourth-quarter revenue increased 6.1% year-over-year to $956.7 million, which beat the consensus estimate of $933.6...

 align-technology-launches-itero-lumina-intraoral-scanner

Powered by the new iTero Multi-Direct Capture™ technology, the iTero Lumina scanner quickly5, easily1, and accurately3 captures...

 align-tech-q4-2023-adj-eps-242-beats-218-estimate-sales-95670m-beat-93367m-estimate

Align Tech (NASDAQ:ALGN) reported quarterly earnings of $2.42 per share which beat the analyst consensus estimate of $2.18 by 1...

 earnings-scheduled-for-january-31-2024

Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue...

 ubs-maintains-neutral-on-align-tech-raises-price-target-to-260

UBS analyst Kevin Caliendo maintains Align Tech (NASDAQ:ALGN) with a Neutral and raises the price target from $200 to $260.

 align-techs-earnings-outlook
Align Tech's Earnings Outlook
01/30/2024 15:01:57

 what-happened-with-align-technology-stock

Align Technology, Inc. (NASDAQ: ALGN) shares traded higher on Monday. The stock has jumped over the past week, here's a loo...

 align-technology-announced-that-the-us-fda-cleared-aligns-invisalign-palatal-expander-system-for-commercial-availability-in-the-us

Invisalign® Palatal Expanders offer doctors a removeable, safe, and clinically effective alternative to traditional palatal exp...

 us-stocks-eye-7-day-winning-streak-as-mortgage-rates-fall-below-7-yields-tumble-whats-driving-markets-thursday

It’s shaping up to be a positive Thursday on Wall Street, with risk sentiment remaining robust after the Federal Reserve effect...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION